Healthtech Startups

Buglance offers an online crowdtesting service that connects companies with a global network of testers to evaluate product quality and gather end-user feedback. Clients can target testers by country, age, gender, device, and OS version.

1 investor

Glance Care is a health insurance technology company founded in 2019 that develops digital solutions for the Saudi Arabian healthcare system. The company focuses on making health insurance more accessible and affordable through innovative technology and data analytics.

1 investor

Glassbeam analyzes complex data generated by connected machines using AI/ML to deliver actionable business intelligence. The company serves organizations across industries including healthcare, helping them optimize operational efficiency and reduce downtime.

1 investor

Glean is a urodynamics (UDS) diagnostic system that uses an abdominal sensor to measure bladder function in a natural setting, without catheters or forced bladder filling and emptying. It is aimed at clinicians diagnosing and monitoring bladder conditions.

1 investor

Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs. The platform targets chronic disease treatments, particularly for inflammatory, respiratory, dermatological, and oncological indications, with a focus on improved accessibility and affordability for resource-limited healthcare settings.

1 investor

Glimmer is a mental health company that provides access to psychotherapy and clinical mental health care. The company connects clients with experienced therapists for evidence-based treatment of conditions including trauma, PTSD, anxiety, and depression.

1 investor

GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.

1 investor

IHME is an independent research institute at the University of Washington School of Medicine that generates scientific evidence on global health outcomes, disease burden, and forecasting to inform policy and health system decisions. The organization develops health metrics, applies AI and statistical methods to health data analysis, and studies health system capacity, climate impacts on health, and health equity across populations worldwide.

1 investor

Global Cord Blood Corporation is China's leading provider of umbilical cord blood collection, laboratory testing, and hematopoietic stem cell processing and storage services. The company operates as a specialized biobank serving patients and families seeking cord blood banking and stem cell therapies.

1 investor

Global Health Metrics provides population health analytics and risk assessment tools for health plans, employers, and healthcare providers. The company uses data analysis and health risk assessments to identify high-risk individuals, manage population health trends, and support wellness and care delivery decisions.

1 investor

Global Premier Fertility operates a fertility network providing clinical and executive leadership for reproductive healthcare services.

1 investor

Global Health Uganda is a not-for-profit research organization that provides infrastructure, management systems, and capacity-building support for scientists conducting research on child health, neurodevelopment, and interventions. Based in Uganda, the organization facilitates collaborative research and manages research grants for health scientists.

1 investor

Global Key Solutions offers KeyPedia, a data intelligence platform for life science companies that interprets and connects regulatory data—such as warning letters, inspection reports, and QMS data—and applies a risk score to support quality and regulatory compliance decisions. It integrates citable evidence and computed signals into the professional tools, AI agents, and workflows used by regulatory and quality teams.

1 investor

GLOBOGATE recruits international healthcare professionals and trainees — including nurses, OTA, ATA, physiotherapists, occupational therapists, and MTA — from countries such as Colombia, Uzbekistan, the Philippines, India, Iran, Tunisia, Egypt, and Morocco for hospitals and care facilities in Germany. It provides language and professional training plus on-site support to help these workers integrate and build long-term careers in the German healthcare sector.

1 investor

Globus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.

1 investor

Gloria.care runs an online platform for finding and booking care accommodations (such as short-term or respite care stays), connecting families and informal caregivers with care providers. It also serves hospitals and care professionals who need to refer patients who cannot (temporarily) return home after hospitalization, and lets families leave reviews on service quality.

1 investor

Glow provides a suite of mobile applications for women's health tracking, including ovulation prediction, pregnancy monitoring, and baby health management. The platform serves women and families seeking to track fertility, prenatal health, and child development, and generates revenue through premium subscriptions and health product sales.

1 investor

Glucose Republic builds software that predicts an individual's postprandial glucose and digestive response to whole meals before eating, modeling food matrices, digestive kinetics, and circadian physiology rather than relying on retrospective calorie logging. It is aimed at people managing blood glucose and diabetes, developed with medical device rigor and patent-pending prediction methods.

1 investor

Medical device company developing the CGM-305, a wearable non-invasive continuous glucose monitor using thermal infrared sensing.

1 investor

Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer. The company operates in the biomedical diagnostics field within the healthcare industry.

1 investor

Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity. Its approach originated from research on how certain bariatric surgeries improve glucose and metabolic regulation and produce sustained weight loss.

1 investor

1 investor

Gnomica develops small-molecule drug inhibitors that target bacterial pathways as a treatment for cancer.

1 investor

Gnosis Health builds longitudinal clinical intelligence tools that provide continuous, individualised care between medical appointments, focused on chronic disease management. The company applies health data analysis to support patients with long-term conditions.

1 investor